Core Scientific, Inc. (CORZQ)
OTCMKTS: CORZQ · Delayed Price · USD
0.328
0.00 (0.00%)
Mar 16, 2023, 12:00 AM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 544.48 | 60.32 | 59.52 |
| Revenue Growth (YoY) | 802.66% | 1.34% | - |
| Cost of Revenue | 305.62 | 50.93 | 49 |
| Gross Profit | 238.86 | 9.39 | 10.53 |
| Selling, General & Admin | 64.67 | 16.33 | 17.54 |
| Research & Development | 7.67 | 5.27 | 5.48 |
| Other Operating Expenses | 35.03 | -5.88 | -0.81 |
| Operating Expenses | 107.37 | 15.72 | 22.21 |
| Operating Income | 131.49 | -6.33 | -11.69 |
| Interest Expense / Income | 44.35 | 4.44 | 0.24 |
| Other Expense / Income | 24.07 | 1.44 | - |
| Pretax Income | 63.08 | -12.21 | -11.92 |
| Income Tax | 15.76 | 0 | 0 |
| Net Income | 47.31 | -12.21 | -11.92 |
| Preferred Dividends | 0 | 10.48 | 0 |
| Net Income Common | 47.31 | -22.68 | -11.92 |
| Shares Outstanding (Basic) | 130 | 98 | 99 |
| Shares Outstanding (Diluted) | 146 | 98 | 99 |
| Shares Change | 48.03% | -0.19% | - |
| EPS (Basic) | 0.37 | -0.23 | -0.12 |
| EPS (Diluted) | 0.32 | -0.23 | -0.12 |
| Free Cash Flow Per Share | -3.71 | -0.38 | -0.39 |
| Gross Margin | 43.87% | 15.57% | 17.69% |
| Operating Margin | 24.15% | -10.49% | -19.63% |
| Profit Margin | 8.69% | -37.61% | -20.03% |
| Free Cash Flow Margin | -88.38% | -62.06% | -63.98% |
| Effective Tax Rate | 24.99% | - | - |
| EBITDA | 140.79 | 1.63 | -5.57 |
| EBITDA Margin | 25.86% | 2.71% | -9.36% |
| Depreciation & Amortization | 33.36 | 9.4 | 6.12 |
| EBIT | 107.43 | -7.77 | -11.69 |
| EBIT Margin | 19.73% | -12.88% | -19.63% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).